A detailed history of Fragasso Group Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Fragasso Group Inc. holds 2,008 shares of NVO stock, worth $175,438. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,008
Previous 1,593 26.05%
Holding current value
$175,438
Previous $227,000 5.29%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$119.07 - $145.42 $49,414 - $60,349
415 Added 26.05%
2,008 $239,000
Q2 2024

Jul 08, 2024

BUY
$122.71 - $146.91 $195,477 - $234,027
1,593 New
1,593 $227,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fragasso Group Inc. Portfolio

Follow Fragasso Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.